Axon Enterprise, Inc. financials

AXON CIK 0001069183

Source: EDGAR filings · Built 2026-06-02T02:24:55Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 75.08M 329.53M 129.63M 179.56M 74.61M -34.15M
EBITDA 21.09M 106.97M 176.16M 116.09M -144.46M -1.68M
Working Capital 2.24B 619.61M 1.63B 1.20B 690.97M 725.62M
Net Debt 715.51M 276.28M 120.06M 363.78M -329.35M -131.06M
Gross Margin 59.65% 59.61% 61.22% 61.16% 63.04% 61.13%
Operating Margin -2.23% 2.81% 10.05% 7.83% -18.85% -2.08%
Net Margin 4.48% 18.10% 11.26% 12.38% -6.51% -0.25%
Return on Equity (ROE) 3.84% 16.20% 10.88% 11.56% -5.36% -0.18%
Return on Assets (ROA) 1.78% 8.43% 5.16% 5.15% -3.34% -0.12%
Current Ratio 2.53× 1.37× 3.14× 3.00× 2.65× 3.83×
Debt-to-Equity 0.59× 0.31× 0.44× 0.56× 0.03× 0.03×
Effective Tax Rate -556.98% 1.17% -11.92% 25.13% 58.70% 72.60%
Cash Conversion Ratio 1.70× 1.08× 1.08× 1.60× -2.21× -22.32×
Accruals Ratio -0.01× -0.01× -0.00× -0.03× -0.11× -0.03×
SBC % of Revenue 22.82% 18.37% 8.42% 8.94% 35.04% 19.61%
CapEx Coverage 1.55× 5.18× 3.17× 4.22× 2.50× 0.53×
Free Cash Flow Per Share $0.91 $4.19 $1.72 $2.48 $1.13 $-0.55

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 376.11× 123.82× 110.87× 81.74×
P/FCF 623.07× 141.68× 150.38× 67.03× 139.28×
FCF Yield 0.16% 0.71% 0.67% 1.49% 0.72%
EV / EBITDA 2194.45× 428.30× 111.10× 105.29×
P/S 16.39× 21.87× 12.46× 9.99× 12.86× 11.47×
P/B 14.05× 19.56× 12.04× 9.33× 10.60× 8.00×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 2.78B 2.08B 1.56B 1.19B 865.64M 681.00M
Cost of Goods and Services Sold 1.12B 841.15M 605.25M 461.03M 319.92M 264.67M
Gross Profit 1.66B 1.24B 955.45M 726.11M 545.72M 416.33M
Research and Development Expense 684.31M 441.59M 303.72M 233.81M 194.03M 123.19M
Selling, General and Administrative Expense 1.04B 741.25M 494.88M 399.33M 514.85M 307.29M
Operating Expenses 1.72B 1.18B 798.60M 633.14M 708.87M 430.48M
Operating Income (Loss) -62.08M 58.54M 156.85M 92.97M -163.15M -14.15M
Income Tax Expense (Benefit) -105.68M 4.47M -18.72M 49.31M -80.06M -4.57M
Net Income (Loss) Attributable to Parent 124.66M 377.03M 175.78M 146.93M -56.34M -1.72M
Earnings Per Share, Basic $1.60 $4.98 $2.37 $2.07 $-0.85 $-0.03
Weighted Average Number of Shares Outstanding, Basic 78.08M 75.75M 74.19M 71.09M 66.19M 61.78M
Earnings Per Share, Diluted $1.51 $4.80 $2.33 $2.03 $-0.91 $-0.03
Weighted Average Number of Shares Outstanding, Diluted 82.37M 78.56M 75.46M 72.53M 66.19M 61.78M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 1.20B 454.84M 598.54M 353.68M 356.33M 155.44M
Assets, Current 3.71B 2.30B 2.39B 1.81B 1.11B 981.95M
Assets 7.00B 4.47B 3.41B 2.85B 1.69B 1.38B
Long-term Debt 1.81B 680.29M
Liabilities, Current 1.47B 1.68B 761.54M 602.65M 418.52M 256.33M
Long-term Debt, Excluding Current Maturities 1.73B 0 677.11M
Liabilities 3.76B 2.15B 1.79B 1.58B 640.36M 404.77M
Stockholders' Equity Attributable to Parent 3.24B 2.33B 1.62B 1.27B 1.05B 976.25M
Common Stock, Shares, Outstanding 80.21M 76.62M 75.30M 71.47M 70.90M 63.77M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 211.34M 408.31M 189.26M 235.36M 124.49M 38.48M
Payments to Acquire Property, Plant, and Equipment 136.26M 78.78M 59.63M 55.80M 49.89M 72.63M
Net Cash Provided by (Used in) Investing Activities -724.93M -490.57M 12.48M -830.97M 252.56M -356.53M
Net Cash Provided by (Used in) Financing Activities 1.25B -45.44M 41.31M 598.10M -174.18M 299.26M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (AXON CIK 0001069183), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

MBIN

MERCHANTS BANCORP

TPB

Turning Point Brands, Inc.

CPRX

CATALYST PHARMACEUTICALS, INC.